These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9223150)

  • 1. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
    Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
    Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.
    Schetters TP; Moubri K; Cooke BM
    J S Afr Vet Assoc; 2009 Jun; 80(2):75-8. PubMed ID: 19831266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of dogs against Babesia canis infection.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Goovaerts D
    Vet Parasitol; 1997 Dec; 73(1-2):35-41. PubMed ID: 9477490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites.
    Adaszek L; Puchalski A; Dec M; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against large Babesia species from dogs.
    Schetters TP; Kleuskens J; Carcy B; Gorenflot A; Vermeulen A
    Parassitologia; 2007 May; 49 Suppl 1():13-7. PubMed ID: 17691601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Bos HJ
    Vet Parasitol; 1994 Apr; 52(3-4):219-33. PubMed ID: 8073606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture.
    Schetters TP; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1992 May; 14(3):295-305. PubMed ID: 1625906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble parasite antigens from Babesia canis do not directly activate the kallikrein system in dogs infected with Babesia canis.
    Finizio AL; Kleuskens JA; Van De Crommert J; Gorenflot A; Carcy B; Schetters TP
    Vet Parasitol; 2011 Mar; 176(2-3):132-8. PubMed ID: 21130577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
    Sunaga F; Arai S; Itoh S; Taharaguchi S
    Parasitol Res; 2014 May; 113(5):1681-6. PubMed ID: 24535736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.
    Cao S; Mousa AA; Aboge GO; Kamyingkird K; Zhou M; Moumouni PF; Terkawi MA; Masatani T; Nishikawa Y; Suzuki H; Fukumoto S; Xuan X
    Acta Parasitol; 2013 Dec; 58(4):619-23. PubMed ID: 24338330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.
    Fukumoto S; Tamaki Y; Shirafuji H; Harakawa S; Suzuki H; Xuan X
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):557-9. PubMed ID: 15817768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells.
    Fukumoto S; Xuan X; Takabatake N; Igarashi I; Sugimoto C; Fujisaki K; Nagasawa H; Mikami T; Suzuki H
    Infect Immun; 2004 Mar; 72(3):1795-8. PubMed ID: 14977989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies against Babesia canis in dogs in an endemic area.
    Bobade PA; Oduye OO; Aghomo HO
    Rev Elev Med Vet Pays Trop; 1989; 42(2):211-7. PubMed ID: 2626574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.